Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Søren Friis

Showing results (1-10 of 230) with videos related to

Pageof 23
Sort By:
Cancer Investigation|June 17, 2006
Statin use and cancer risk: an epidemiologic reviewSøren Friis, Jørgen H Olsen
International Journal of Cancer|October 16, 2012
Cancer risk in long-term users of vitamin K antagonists: a population-based case-control studyAnton Pottegård, Søren Friis, Jesper Hallas
Pharmacoepidemiology and Drug Safety|June 21, 2018
Use of proton pump inhibitors and risk of pancreatic cancerBlánaid Hicks, Søren Friis, Anton Pottegård
Clinical Epidemiology|May 30, 2014
Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999-2012Morten Schmidt, Jesper Hallas, Søren Friis
Ugeskrift for Laeger|May 19, 2004
[From cancer statistics to the Cancer Registry]Jørgen Helge Olsen, Lene Mellemkjaer, Søren Friis
Epidemiology (Cambridge, Mass.)|July 14, 2006
Malignant melanoma and other types of cancer preceding Parkinson diseaseJørgen H Olsen, Søren Friis, Kirsten Frederiksen
Current Diabetes Reports|August 27, 2014
The epidemiology of diabetes and cancerBendix Carstensen, Marit Eika Jørgensen, Søren Friis
Danish Medical Bulletin|May 4, 2011
Tympanotomy and sealing of the round window for treatment of sudden deafnessJamshaid Ul-Mulk, Søren Friis, Christoffer Holst Hahn
Expert Opinion on Drug Discovery|July 11, 2020
Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decadeAlison Obergrussberger, Søren Friis, Andrea Brüggemann, et al.
British Journal of Clinical Pharmacology|October 10, 2012
Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control studyAnton Pottegård, Søren Friis, Morten Andersen, et al.
Pageof 23

Showing results (1-10 of 230) with videos related to

Sort By:
Pageof 23
Cancer Investigation|June 17, 2006
Statin use and cancer risk: an epidemiologic reviewSøren Friis, Jørgen H Olsen
International Journal of Cancer|October 16, 2012
Cancer risk in long-term users of vitamin K antagonists: a population-based case-control studyAnton Pottegård, Søren Friis, Jesper Hallas
Pharmacoepidemiology and Drug Safety|June 21, 2018
Use of proton pump inhibitors and risk of pancreatic cancerBlánaid Hicks, Søren Friis, Anton Pottegård
Clinical Epidemiology|May 30, 2014
Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999-2012Morten Schmidt, Jesper Hallas, Søren Friis
Ugeskrift for Laeger|May 19, 2004
[From cancer statistics to the Cancer Registry]Jørgen Helge Olsen, Lene Mellemkjaer, Søren Friis
Epidemiology (Cambridge, Mass.)|July 14, 2006
Malignant melanoma and other types of cancer preceding Parkinson diseaseJørgen H Olsen, Søren Friis, Kirsten Frederiksen
Current Diabetes Reports|August 27, 2014
The epidemiology of diabetes and cancerBendix Carstensen, Marit Eika Jørgensen, Søren Friis
Danish Medical Bulletin|May 4, 2011
Tympanotomy and sealing of the round window for treatment of sudden deafnessJamshaid Ul-Mulk, Søren Friis, Christoffer Holst Hahn
Expert Opinion on Drug Discovery|July 11, 2020
Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decadeAlison Obergrussberger, Søren Friis, Andrea Brüggemann, et al.
British Journal of Clinical Pharmacology|October 10, 2012
Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control studyAnton Pottegård, Søren Friis, Morten Andersen, et al.
Pageof 23